The FDA has cleared BeOne Medicines’ BCL2 blocker sonrotoclax for the treatment of certain patients with mantle cell lymphoma ...

Not all cancers respond to the same treatments or have the same genetic origins. Epstein–Barr virus (EBV), a common and ...

Hematopoietic Stem-Cell Transplantation: Exploring the Latest Advances and Gaps in Disparities, Psychosocial and Symptom Management Interventions, and Chronic Graft-Versus-Host Disease Care ...

A Putnam County high school sophomore was diagnosed with a rare form of lymphoma and is beginning intensive chemotherapy ...

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Lymphoma is a cancer of lymphocyte cells. Lymphocytes are one of our white blood cells and they play an important role in helping our body to fight off infection. They are present in lymph fluid which ...

Sonrotoclax (Beqalzi) indicated for relapsed or refractory mantle cell lymphoma ...

Cancer can affect all parts of the body, including the blood. Leukemia and lymphoma are types of blood cancer. It’s estimated that in 2016 in the United States, approximately 60,000 people will be ...

New research shows that lymphoma survivors often face long-term peripheral neuropathy, which may be more severe than what ...

EZH2 inhibitor tazemetostat (Tazverik) is being withdrawn from global markets ...

MISSION VIEJO, Calif. (KABC) -- Actor Jeff Bridges announced he's fighting a major battle. The Oscar winner on Tuesday tweeted that he's been diagnosed with lymphoma. "I have been diagnosed with ...

New population studies suggest that tattoos may be associated with a higher risk for lymphoma and skin cancer, although ...